Mrs Nayibe Olaya, OT | |
53 Russell Rd, Garden City, NY 11530-1933 | |
(516) 414-7853 | |
Not Available |
Full Name | Mrs Nayibe Olaya |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 53 Russell Rd, Garden City, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205067097 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 006637-1 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Nayibe Olaya, OT 53 Russell Rd, Garden City, NY 11530-1933 Ph: (516) 414-7853 | Mrs Nayibe Olaya, OT 53 Russell Rd, Garden City, NY 11530-1933 Ph: (516) 414-7853 |
News Archive
Tim Gilbo, the World Bank's director in Malawi, announced on Tuesday that the organization will grant the country $30 million, which will be used to "increase access to prevention, treatment and mitigation services with a focus on behavioural change," SAPA/News24.com reports. Gilbo also said the country should "identify and promote those programmes that are working and drop or redesign those that are not bearing any fruits." UNAIDS Malawi coordinator Desmond Johns said HIV/AIDS is "arguably the single consistent threat in overall development" for Malawi (9/22).
In the first large trial of its kind in the United States, researchers have shown that estrogen-lowering drugs can shrink tumors and reduce mastectomy rates for patients with stage 2 or 3 breast cancer.
The replacement of animals as test subjects is one step closer to reality with the successful testing of multi-organ "human-on-a-chip" models to recapitulate the 28-day experiments typically used in animals to evaluate the systemic toxicity of drug and cosmetic compounds.
Genaissance Pharmaceuticals received a Notice of Allowance from the United States Patent and Trademark Office for a patent claiming methods for identifying correlations between the safety and efficacy of drugs and patients' unique genetic signatures.
Patients with sickle cell anemia (SCA) develop heart complications and nearly a quarter die a sudden death. Now, researchers have linked malfunctioning molecular pathways to specific heart anomalies in SCA that result from progressive fibrosis and result in sudden death.
› Verified 6 days ago
Mr. Joseph Pesce, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 E Gate Blvd, Garden City, NY 11530 Phone: 516-745-8050 | |
Lara Borg, MSOTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 E Gate Blvd, Garden City, NY 11530 Phone: 516-745-8070 Fax: 516-745-8055 | |
Patricia Marie Gasiewski, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Garden City Plz Ste 350, Garden City, NY 11530 Phone: 516-531-7210 | |
Jamie Silver, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Garden City Plz Ste 350, Garden City, NY 11530 Phone: 516-747-9030 | |
Epilepsy Foundation Of Long Island Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 506 Stewart Ave, Garden City, NY 11530 Phone: 516-739-7733 | |
Ms. Regan Samona Tuccillo, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 E Gate Blvd, Garden City, NY 11530 Phone: 516-745-8050 | |
Ms. Christina Marie Pashayan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3 Whitehall Blvd S, Garden City, NY 11530 Phone: 516-697-1335 |